All News

Nanotechnology looks like generating more paper than profits as yet another policy review gets under way.

For the last three years, the French parliament has been struggling with legislation on copyright and associated rights in information society. It has surfaced in the headlines, portrayed as a fight to force Apple to make its iTunes music downloads playable on competing music boxes. But there's more involved.

A key distinction between physical and intellectual property is that the value of the latter is created as much by sharing it as by owning it. How to share it, between creator and enabler, is a particularly acute issue within the academic environment - as indicated by a recent, noteworthy debate on the subject in Sweden.

Finland wants to use its six months presiding over the EU to change innovation policy. It picks up the gauntlet at a meeting of competition ministers next week.

As the European Commission ponders the single European patent, the European Patent Office is under attack from national patent offices that want some of its functions.

Germany's academic spin-outs are not such a force for developing the economy after all, according to an in depth study of 20 of their number.

The Health Research Board of Ireland is to join the consortium of UK research funders developing a single gateway to the largest pool of patients in the world.

Israel’s high-tech incubator companies are joining the stock market – and perhaps providing a new model for technology commercialisation

Technology transfer is a sensitive and complex process. Changing one factor won’t provide the magic bullet, says Anna S. Nilsson, Science and Technology Attaché at the Swedish Embassy in Washington DC.

Orla Protein Technologies, a spin-out from the University of Newcastle upon Tyne, UK, is looking to raise £3 million in a series A funding round for the next stage of its development.

European food manufacturers are being offered access to a new software tool that takes the trial and error out of devising and developing convenience food recipes,.

TeGenero, the company behind the drug trial fiasco that put six healthy volunteers into intensive care, has announced it is filing for insolvency.

Swedish spin-out Denator Biotechnology is raising money to fund development of its technology that analyses protein samples without adulterating them with added reagents.

German company Q-Cells AG has taken a stake in Swiss university spin-off VHF Technologies, which makes flexible plastic films for solar panels.

Innovation will be a priority for the EU over the next six months